Pharmacokinetic Study of Fondaparinux in Outpatients With Renal Dysfunction

Edoxaban Steady-State PK/PD in Adults With Nephrotic Syndrome

NCT07116239 ·Status: NOT_YET_RECRUITING ·Phase: NA

A Study to Evaluate the Blood Levels, Safety, and Tolerability of PF-00734200 in Subjects With Impaired Kidney Function and Normal Kidney Function

NCT00596518 ·Status: COMPLETED ·Phase: PHASE1

Safety and Pharmacokinetics of MK-2060 in Older Participants With End-Stage Renal Disease on Hemodialysis (MK-2060-004)

NCT03873038 ·Status: COMPLETED ·Phase: PHASE1

Pharmacokinetics of Dabigatran Etexilate (Pradaxa®) During Haemodialysis

NCT01241539 ·Status: COMPLETED ·Phase: PHASE1

Chronic Anticoagulation With a Reduced Dose Regimen of Rivaroxaban in End-stage Renal Disease Patients

NCT05410275 ·Status: UNKNOWN ·Phase: PHASE3

Study of a Single Intravenous (IV) Dose of MK-3402 in Participants With Impaired Renal Function and in Healthy Controls (MK-3402-004)

NCT04678505 ·Status: TERMINATED ·Phase: PHASE1

An Evaluation of the Pharmacokinetics and Pharmacodynamics of Oral Dabigatran Etexilate in Hemodialysis Patients

NCT01590823 ·Status: COMPLETED ·Phase: PHASE1

A Research Study Looking Into Levels of the Medicine NNC0385-0434 in the Body and How Well it is Tolerated in Participants With Impaired Kidney Function Compared to Participants With Normal Kidney Function

NCT05094934 ·Status: TERMINATED ·Phase: PHASE1

A Clinical Study to Assess the Safety of PEG-Hirudin (SPP200) Compared to Heparin in Patients Who Are on Haemodialysis

NCT00074620 ·Status: COMPLETED ·Phase: PHASE2

Klotho Gene Polymorphism in Dialyzed Patients With Hyperphosphatemia

NCT00374712 ·Status: TERMINATED

A Prospective Multi-dose Study of Apixaban in Subjects With Nephrotic Syndrome

NCT04278729 ·Status: COMPLETED ·Phase: PHASE1

A Phase 2 Dose-finding Study of TS-172 in Hyperphosphatemia Patients on Hemodialysis

NCT05699239 ·Status: COMPLETED ·Phase: PHASE2

HENOX: Enoxaparine in Hemodialysis

NCT00347490 ·Status: COMPLETED ·Phase: PHASE4

Assessment of the Pharmacokinetics of GSK1278863 and Metabolites in Normal Subjects and Subjects With Renal Impairment

NCT01406340 ·Status: TERMINATED ·Phase: PHASE1

Pharmacokinetic Assessment of Single-Dose Odanacatib (MK-0822) in Subjects With Severe Renal Insufficiency (MK-0822-067)

NCT01512667 ·Status: COMPLETED ·Phase: PHASE1

Study to Evaluate the Pharmacokinetics and Pharmacodynamics of Dabigatran Etexilate in Patients With Stable Severe Renal Disease.

NCT01711853 ·Status: COMPLETED ·Phase: PHASE1

A Study to Evaluate JNJ-64565111 Pharmacokinetics and Safety in Adult Participants With Varying Degrees of Renal Function

NCT03546205 ·Status: COMPLETED ·Phase: PHASE1

Rituximab to Prevent Recurrence of Proteinuria

NCT01164098 ·Status: TERMINATED ·Phase: PHASE3

Pharmacokinetics of Somatropin in Patients With End Stage Renal Disease Receiving Chronic Haemodialysis

NCT01502137 ·Status: COMPLETED ·Phase: PHASE1

Pentoxifylline and Progression of Chronic Kidney Disease in Moderate-to-high Risk Patients

NCT00285298 ·Status: COMPLETED ·Phase: PHASE3

Study of the Oral Factor D (FD) Inhibitor ALXN2050 in PNH Patients as Monotherapy

NCT04170023 ·Status: TERMINATED ·Phase: PHASE2

Pharmacokinetic Comparison Of All FK-506 Formulations

NCT02339246 ·Status: COMPLETED ·Phase: PHASE3

An Trial of Two Dosing Regimens of AP214 for the Prevention of Kidney Injury in Patients Undergoing Cardiac Surgery

NCT01256372 ·Status: COMPLETED ·Phase: PHASE2

Efficacy and Safety of RMC-035 in Subjects at High Risk for Acute Kidney Injury Following Open-Chest Cardiac Surgery

NCT05126303 ·Status: TERMINATED ·Phase: PHASE2

The Reducing Adverse Outcomes in Dialysis by Adjusting the pRescription for Dialysate Potassium Trial

NCT07051447 ·Status: NOT_YET_RECRUITING ·Phase: NA